Transcriptome analysis of human hypertrophic cardiomyopathy reveals inhibited cardiac development pathways in children
Authors:
Open Access
- 5 December 2023
- Vol. 27 (1) , 108642
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82100377)
- Beijing Nova Program (Z211100002121046)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20220531091605012)
This publication has 37 references indexed in Scilit:
- Structure, sarcomeric organization, and thin filament binding of cardiac myosin-binding protein-CPflügers Archiv - European Journal of Physiology, 2014
- Alterations in mitochondrial function in cardiac hypertrophy and heart failureHeart Failure Reviews, 2012
- Dual transcriptional activator and repressor roles of TBX20 regulate adult cardiac structure and functionHuman Molecular Genetics, 2012
- FGF10/FGFR2b signaling is essential for cardiac fibroblast development and growth of the myocardiumDevelopment, 2011
- Redundant and dosage sensitive requirements for Fgf3 and Fgf10 in cardiovascular developmentDevelopmental Biology, 2011
- The FGF-BMP Signaling Axis Regulates Outflow Tract Valve Primordium Formation by Promoting Cushion Neural Crest Cell DifferentiationCirculation Research, 2010
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant miceCardiovascular Research, 2006
- The Epidemiology of Childhood Cardiomyopathy in AustraliaNew England Journal of Medicine, 2003
- Rapid Transition of Cardiac Myocytes from Hyperplasia to Hypertrophy During Postnatal DevelopmentJournal of Molecular and Cellular Cardiology, 1996